Pre-Anæsthetics -- these agents are typically administered intramuscularly or subcutaneously and as used to aid the induction of anæsthesia prior to surgery.
Glycopyrrolate -- also an anti-cholinergic, it does not cross the blood brain barrier as effectively as atropine. It is also used to treat bradycardia and hypersalivation in dogs.
In general, dogs are more sensitive to the effects of acepromazine (especially giant breeds, greyhounds, and boxers), however terriers exhibit a high degree of resistance to its effects.
Large animals may exhibit a protrusion of the penis with acepromazine. This could lead to injury due to swelling and a permanent paralysis of the penile retractor muscle. Caution should be taken when using acepromazine in stallions or show animals. Additionally, some horses may exhibit paradoxical excitation, sweating, trembling, and convulsions with acepromazine.
In horses and dogs, acepromazine may cause a prolapse of the membrana nictitans (a secondary eyelid), which would also decrease the value of a show animal.
Acepromazine may turn the urine a pink to reddish-brown colour.
In horses, xylazine produces visceral analgesia better than meperidine, butorphanol, or pentazocine. In horses, xylazine may also cause penile prolapse, but no permanent paralysis is produced. The sedation in horses is accompanied by head-lowering, relaxed facial muscles, and a pendulous lower lip. Occasionally, xylazine may cause a paradoxical increase startle reflex. The caregiver should be wary of kicks.
In cats (and rarely in dogs) xylazine may cause emesis. It is used as an emetic agent in feline poisonings (producing emesis within about 3-5 minutes).
In cattle (and less frequently in cats and horses), xylazine may cause polyuria, thought to be mediated by a decrease in ADH release or activity.
Species differences occur in the potency of xylazine. Ruminants are extremely sensitive to its effects, requiring only 1/10 the equine dose. Alternately, swine are very resistant and must be given 20-30 times the ruminant dose (for this reason, xylazine is rarely used in swine).
Medotomidine (Domitor®) -- also a vet-only product acting as an alpha-2 agonist. Domitor® is being marketed specifically for combination use with another Pfizer product, atipamezole (Antisedan®), which acts as an alpha-2 antagonist. The combination is designed for balanced anæsthesia and prevention of overdose by the use of Domitor® alone.
Ketamine (Ketaset®, Vetalar®) -- This anæsthetic is though to block NMDA receptors. However it may also interact with serotonin, noradrenaline, or dopamine activity. It is a phencyclidine congener and is classed in human pharmacology as a dissociative anæsthetic. It is analgesic and amnestic but, at normal doses, does not depress the cardiopulmonary systems. However, overdose may cause respiratory depression.
In dogs, a combination of ketamine and xylazine (a common procedure in veterinary practice) may cause arrhythmias and pulmonary œdema.
In horses, higher doses that expected may be required for ponies, Arabians, Hackneys, and thoroughbreds. The horse should not be disturbed until they are fully recovered.
Dogs are especially sensitive to cardiac effects including tachycardia, negative inotropy, decreased stroke volume, decreased mean arterial pressure, and decreased peripheral resistance.
Other barbiturates commonly employed include thiopental (Pentothal®), phenobarbitone, and pentobarbitone.